Abstract
This clinical guidance is for COVID-19 immunisation providers and program staff and is based on currently available data. It provides recommendations on the use of the Pfizer COVID-19 vaccine Comirnaty and the AstraZeneca COVID-19 Vaccine. It will be updated as new information and vaccines become available. Changes from the previously available ATAGI Clinical guidance on COVID-19 vaccines in Australia (v1.0) include:
- Inclusion of data on the AstraZeneca COVID-19 Vaccine
- Changes in COVID-19 vaccine precautions for people with a history of allergy
Recommendation
Western Pacific
Australia
Pfizer-BioNTech vaccine
AstraZeneca COVID-19 vaccine
COVID-19
